Clinical Trial Update: Duke APOL1 Research Biorepository

View source ↗

Summary

Duke University reports that the APOL1 Research Biorepository trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Snippet

Sponsor: Duke University | Conditions: End Stage Kidney Disease | Status: RECRUITING